Moreover, Western blotting assays showed that the amount of MPZL1 protein was significantly up-regulated in glioma tissues compared with the normal (Fig. 1I; one-way ANOVA, P < 0.01). This evidence concerns the gene MPZL1 and central nervous system cancer.